Accuray traded at $2.00 this Tuesday June 28th, decreasing $0.11 or 5.21 percent since the previous trading session. Looking back, over the last four weeks, Accuray lost 3.85 percent. Over the last 12 months, its price fell by 56.71 percent. Looking ahead, we forecast Accuray to be priced at 2.00 by the end of this quarter and at 1.85 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Abbott 106.97 -2.11 -1.93% -8.74%
AngioDynamics 19.24 -0.50 -2.53% -28.85%
Accuray 2.00 -0.11 -5.21% -56.71%
AtriCure 39.66 -1.05 -2.58% -49.99%
Natus Medical 32.90 -0.21 -0.63% 25.43%
Boston Scientific 37.50 -0.32 -0.85% -13.25%
Artivion Inc 18.64 -0.66 -3.42% -34.62%
Cardiovascular Systems 14.62 -0.19 -1.28% -65.87%
Edwards Lifesciences 94.73 -2.08 -2.15% -8.55%
Hologic 69.78 -1.68 -2.35% 1.35%
Inogen 24.42 -1.21 -4.72% -62.70%
Mesa Laboratories 194.61 -8.38 -4.13% -27.42%
Orthofix International 23.75 -0.87 -3.53% -40.82%
Surmodics 36.27 -1.39 -3.69% -34.50%
Tandem Diabetes Care 60.34 -0.65 -1.07% -39.77%
Trinity Biotech 1.34 -0.02 -1.25% -55.03%

Indexes Price Day Year
USND 11182 -343.01 -2.98% -23.04%
US2000 1739 -32.90 -1.86% -24.69%

Accuray
Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports market-changing solutions that are designed to deliver radiation treatments. The Company's technologies include the CyberKnife and TomoTherapy platforms, including the Radixact System. The CyberKnife and TomoTherapy platform, which are designed to deliver treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT) and adaptive radiation therapy (ART). The CyberKnife Systems are robotic systems that are used to treat various types of cancer and tumors throughout the body. The CyberKnife Systems track, detect and correct for tumor and patient movement in real-time during the procedure. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.